Immatics NV (IMTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $972.99M
Last updated: Nov 17, 2026 at 11:06 AM ET
Immatics NV (IMTX) Financials: Revenue, Profit and Cash Flow
Immatics NV reported revenue of EUR 48.27M for the fiscal year ended Dec 31, 2025, down 69.0% from the year before. That year, net income was EUR -196.45M with a net margin of -407.0%, operating cash flow was EUR -169.66M and free cash flow was EUR -175.95M. The quarter ended Sep 30, 2026 had revenue of EUR 6.92M and net income of EUR -76.02M.
Revenue and Margins
Over the 7 years to Dec 2025, revenue grew from EUR 3.77M, a compound annual rate of 43.9%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | 48.27M | -69.0% | 100.0% | -377.1% | -407.0% |
| Dec 2024 | 155.84M | +188.6% | 100.0% | -24.8% | 9.8% |
| Dec 2023 | 54.00M | -68.8% | 100.0% | -188.4% | -175.3% |
| Dec 2022 | 172.83M | +397.2% | 100.0% | 17.3% | 16.0% |
| Dec 2021 | 34.76M | +11.2% | 100.0% | -248.2% | -268.5% |
| Dec 2020 | 31.25M | +69.4% | -114.7% | -223.1% | -676.0% |
| Dec 2019 | 18.45M | +389.4% | -117.3% | -178.9% | -172.0% |
| Dec 2018 | 3.77M | N/A | -801.1% | -912.7% | -834.1% |
Income Statement
In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 48.27M | 155.84M | 54.00M | 172.83M | 34.76M | 31.25M | 18.45M | 3.77M |
| Cost of revenue | N/A | 148.08M | 118.66M | 106.78M | 87.57M | 67.08M | 40.09M | 33.97M |
| Gross profit | 48.27M | 155.84M | 54.00M | 172.83M | 34.76M | -35.83M | -21.64M | -30.20M |
| Research and development | 183.83M | 148.08M | 118.66M | 106.78M | 87.57M | 67.08M | 40.09M | 33.97M |
| Operating income | -182.02M | -38.62M | -101.72M | 29.95M | -86.29M | -69.72M | -33.01M | -34.41M |
| Net income | -196.45M | 15.22M | -94.65M | 27.70M | -93.33M | -211.28M | -31.74M | -31.44M |
| EBITDA | N/A | 34.46M | -88.93M | 50.04M | N/A | -65.29M | -28.46M | -30.16M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.92M | 9.14M | 7.61M | 19.76M | 5.19M | 4.74M | 18.58M | 56.25M | 50.56M | 18.75M | 30.27M | 15.92M |
| Gross profit | 6.92M | 9.14M | 7.61M | 19.76M | 5.19M | 4.74M | 18.58M | 56.25M | 50.56M | 18.75M | 30.27M | 15.92M |
| Operating income | -78.54M | -67.20M | -66.06M | -38.88M | -54.63M | -53.13M | -35.37M | 903.00K | 514.00K | -26.56M | -13.47M | -27.71M |
| Net income | -76.02M | -62.49M | -57.81M | -35.70M | -50.55M | -70.35M | -39.85M | 44.86M | -8.57M | -17.99M | -2.24M | -26.15M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of EUR 2.76M by 343.01M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 562.10M | 696.15M | 509.96M | 407.82M | 174.65M | 254.65M | 134.28M | 61.32M |
| Current assets | 503.79M | 629.55M | 449.37M | 377.15M | 152.21M | 238.99M | 124.00M | 55.29M |
| Cash and equivalents | 345.77M | 236.75M | 218.47M | 148.52M | 132.99M | 207.53M | 103.35M | 39.37M |
| Total liabilities | 78.20M | 121.30M | 292.35M | 204.47M | 150.58M | 167.26M | 175.11M | 70.49M |
| Short-term debt | 2.76M | 2.85M | 2.60M | 2.16M | 2.71M | 1.88M | 1.41M | N/A |
| Shareholder equity | 483.89M | 574.84M | 217.62M | 203.35M | 24.06M | 87.39M | -41.85M | -10.41M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 565.72M | 485.53M | 543.83M | 562.34M | 518.56M | 567.30M | 641.69M | 696.15M | 577.23M | 626.97M | 653.13M | 509.96M |
| Total liabilities | 127.22M | 86.07M | 87.55M | 78.24M | 101.88M | 102.73M | 105.09M | 121.30M | 194.71M | 239.08M | 252.34M | 292.35M |
| Cash and equivalents | 276.61M | 232.36M | 301.65M | 345.92M | 334.92M | 256.63M | 242.84M | 236.75M | 189.20M | 158.14M | 122.09M | 218.47M |
| Shareholder equity | 438.50M | 399.46M | 456.28M | 484.10M | 416.68M | 464.57M | 536.61M | 574.84M | 382.53M | 387.89M | 400.79M | 217.62M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -169.66M | -158.03M | 18.23M | 100.13M | -81.78M | -85.61M | 70.97M | 20.68M |
| Capital expenditures | 6.30M | 16.48M | 30.96M | 6.21M | 5.66M | 7.52M | 2.23M | 507.00K |
| Free cash flow | -175.95M | -174.51M | -12.73M | 93.92M | -87.44M | -93.13M | 68.73M | 20.18M |
| Investing cash flow | 196.70M | -152.39M | -31.39M | -209.79M | 7.49M | -15.95M | -5.06M | -13.51M |
| Financing cash flow | 93.51M | 319.68M | 84.52M | 123.71M | -2.61M | 207.88M | -1.86M | 23.65M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -60.70M | -61.20M | -42.73M | -57.64M | -44.70M | -39.05M | -34.21M | -58.48M | -33.73M | -33.22M | -32.60M | 79.08M |
| Capital expenditures | 802.00K | N/A | 775.54K | 938.58K | 1.08M | 1.56M | 3.13M | 1.73M | 2.80M | 2.77M | 9.23M | 9.29M |
| Free cash flow | -61.50M | N/A | -43.51M | -58.58M | -45.78M | -40.61M | -37.34M | -60.21M | -36.53M | -35.99M | -41.84M | 69.78M |
Frequently Asked Questions About IMTX
What is Immatics NV's annual revenue?
Immatics NV reported revenue of EUR 48.27M for the fiscal year ended Dec 31, 2025.
How fast is Immatics NV's revenue growing?
Revenue was down 69.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -34.6%.
Is Immatics NV profitable?
No. Immatics NV reported net income of EUR -196.45M for the fiscal year ended Dec 31, 2025, with a net margin of -407.0%.
How much free cash flow does IMTX generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of EUR -169.66M minus capital expenditures of EUR 6.30M produced free cash flow of EUR -175.95M.
How much debt does Immatics NV have?
The balance sheet dated Dec 31, 2025 reported short-term debt of EUR 2.76M and cash and equivalents of EUR 345.77M.
IMTX pages: Overview, Financials, Competitors